0955 GMT - Danone has a strong Chinese infant formula business and is the best-placed company to benefit from an improvement in birth rates in the country, Barclays analysts say in a note. The Chinese birth rate rose 6% in 2024 after years of declines, making the outlook for the Chinese infant milk formula "the best we have seen for a decade", they say. This prospect was confirmed by Danone at an analysts' meeting, when the company said that the uptick in births would feed into stage 1-3 formula growth over the next few years, they add. They note that the company already started to see signs of stabilization in the category. "Overall we think these positive developments in the Chinese IMF market go some way to removing one of the key and long-standing bear points on Danone," they add. Shares are flat at 68.07 euros. (michael.susin@wsj.com)
(END) Dow Jones Newswires
February 18, 2025 04:55 ET (09:55 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。